Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195, USA.
J Gastroenterol Hepatol. 2010 Sep;25(9):1485-92. doi: 10.1111/j.1440-1746.2010.06430.x.
Combined hepatocellular-cholangiocarcinoma is a rare primary neoplasm in the liver. It has gained increasing recognition recently, which in part may be due to more extensive sampling of the explants and surgical resection specimens, the diagnostic challenges encountered in the clinical practice, and the yet to be determined clinical outcome, but partly may be attributed to its intriguing histogenesis/cells of origin. This review aims to update combined hepatocellular-cholangiocarcinoma with an emphasis on the pathological diagnosis, including the differential diagnosis and its diagnostic pitfalls, the possible cell of origin of this neoplasm, and its clinical outcome.
肝细胞肝癌-胆管细胞癌是一种罕见的肝脏原发性肿瘤。最近,它越来越受到人们的关注,这部分可能是由于对肝移植和手术切除标本的更广泛采样,在临床实践中遇到的诊断挑战,以及尚未确定的临床结果,但部分原因可能与其有趣的组织发生/起源细胞有关。本综述旨在更新肝细胞肝癌-胆管细胞癌的内容,重点介绍病理诊断,包括鉴别诊断及其诊断陷阱、这种肿瘤的可能起源细胞及其临床结果。